NO Image

26th Global Congress on Biotechnology

Mar 21-22, 2023


Chicago, United States of America

Biotechnology 2023

Welcome message

Warm Welcome to the 26th Global Congress on Biotechnology which is going to be scheduled during March 21-22, 2023 in Chicago, USA brings upon a new platform to share new ideas and discuss all the innovations in the field of biotechnology. Attend our events to hear from notable experts and presenters from around the world as they discuss recent developments in biotechnology.

A new forum for discussing all the advancements in the field of biotechnology will be introduced by Biotechnology 2023. Meet the world's leading experts and presenters at our sessions as they discuss the most recent developments in the field of biotechnology and help to create new breakthroughs. This will provide a fantastic platform for students, researchers, academics, and scientists to present their work and become well-known. To create new innovations and technologies, we cordially invite you all to the Biotechnology 2023 Congress.

Our conference offers a platform for the exchange of information about cellular and biomolecule processes in order to develop technologies and products that benefit both nature and our quality of life. This will offer a great platform for students and young researchers to explore their work.

About Conference

This conference has a great opportunity and potential to understand the perspective of Biotechnology; this is the only platform to circulate your ideas. Biotechnology 2023 conference brings together professors, business giants, Engineers, teachers, doctors, researchers, and therapeutics and diagnostics. Biotechnology 2023 is an excellent opportunity for delegates from universities and institutes to interact with world-class scientists.

In the domains of biotechnology, the conference serves as an international forum for the dissemination of technological developments and research findings. Leading scientists, engineers, and researchers in the field will attend the conference from all over the world. We cordially invite all authors past and future to submit their brand-new research papers and shares their invaluable insights with scholars and scientists all around the world.

Download the flyer by just one click:


The capability is merely elevated to a higher level of precision in the current decade by biotechnology. Similar to prior innovations, biotechnology has great promise for its benefits, particularly in three key areas: improved human health, increased yields, and environmental protection.

Why attend

It enables all engineers and researchers to interact, learn from one another, and work together on a shared project. You should attend because of:

Networking Opportunities | To learn cutting-edge industry knowledge | Improve your presentation and communication skills | To get inspired | To meet experts, scientists and engineers face to face | Add research value | New tips and tactics in your field | Get stronger with new skills


CPD Credits | IOCM Certificate  | One on one meeting with Eminent Speaker from 40 Countries | Live Streaming of the Conference | Keynote sessions by the world's most eminent researchers | Top Industries Representation | Though- provoking Symposia and Workshops | Preconference workshops in all major countries | Nominations for Best Poster Award | Outstanding Young Researcher Award | Group Registration Benefits 

 Target audience

Research Scholars | Scientists | Young Researcher | Biotechnology Industries | Biotech Food Industry | Agro- Industry | Digital medication and Restorative Organizations | Health care business | Buy and sell-side experts | Business partners | Training organization | Industrial Biotechnology affiliations | Biotechnology business people

Market analysis

The size of the worldwide biotechnology market was forecast to be USD 1,023.92 billion in 2021, and from 2022 to 2030, it is anticipated to expand at a CAGR OF 13.9%. Government activities aimed at modernizing the regulatory framework, enhancing approval procedures and reimbursement practices, and standardizing clinical studies all contribute to the market's growth. Personalized medicine's expanding influence and the rise in orphan drug formulations are creating new opportunities for biotechnology applications and attracting new, creative biotechnology firms, which is helping to increase market revenue.

The COVID-19 pandemic has had a favourable effect on the world economy by spurring an increase in opportunities and developments for producing vaccines and drugs to treat the disease. For instance, the COVID-19 vaccine was produced in approximately 11 billion doses globally in 2021, immunizing over half of the world's population within a year.
Furthermore, the success of mRNA vaccines and expedited approval procedures have resulted in a boom in vaccine-related revenues, as shown by a combined revenue generation of roughly USD 31 billion in 2021 from Moderna, Pfizer/BioNTech, and Johnson & Johnson vaccines. The market's expansion has also been aided by the rising need for biotechnology tools for agricultural applications such as micro propagation, molecular breeding, tissue culture, conventional plant breeding, and the development of genetically modified crops, among others.

Additionally, genetically engineered crops and seeds resistant to insects and herbicides are becoming increasingly popular, which is helping the industry expand. The use of biotechnology for the cloning of disease-free and nutritious plant varieties has propelled the agricultural applications for biotechnology, as has the rise in the adoption of tissue culture technology for the production of novel rice variants and disease- and pest-free banana varieties in regions of south Asia and Africa. The industry is additionally fuelled by financing opportunities in tissue engineering and regeneration technologies as well as the existence of a robust pipeline of clinical trials. The Alliance for Regenerative Medicine reports that in 2021, firms working on cell and gene therapies raised approximately USD 23.1 billion in funding globally, an increase of almost 16% over the USD 19.9 billion total from the previous year. The market growth is being considerably impacted by the clinical achievements of top gene therapy players in 2001, such as the promising outcomes of an in vivo CRISPR treatment for transthyretin amyloidosis developed by Intellia Therapeutics and Regeneron. The market is expected to grow as demand for clinical treatments for chronic diseases such as cancer, diabetes, age-related macular degeneration, and practically all types of arthritis rises.

Biotechnology The market size was estimated to be approximately USD 497 billion in 2020, and between 2021 and 2027, it is anticipated to increase at a CAGR of around 9.4%. New scientific disciplines including genomics, metabolomics, and proteomics have emerged as a result of on going molecular biology developments and breakthroughs. The creation of therapeutic proteins and other medicines has been made easier because to the expanding usage of biotech technologies. The demand for medication discovery and development has increased due to the rising prevalence of chronic diseases. Due to the broad scope of the application, it is also being employed more and more in other industrial areas. The market is expanding in part due to increased utilisation in agriculture related to the rising demand for organic products.

                                                          market analysis

Biotechnology is an interdisciplinary, cutting-edge field that uses living things, biological systems, or their derivatives to alter or develop production processes and therapies. It has a significant impact on a variety of industries, including medicine and pharmaceuticals, genetics, food and chemical production, and others. It plays a crucial and comprehensive role in addressing pressing issues pertaining to environmental preservation, food and energy security, and health and wellbeing.

Favourable government initiatives along with collaborations with industry players will drive the market expansion:
In developing nations like India, Brazil, and China, the biotech sector is expanding as a result of favourable government initiatives. Government policies are in line with improving clinical study standards, improving the reimbursement environment, and quickening the product approval process. The Indian government has launched a number of efforts to support the sector. Building a solid foundation for research and innovation is the goal of the Department of Biotechnology's National Biotechnology Development Strategy. This approach would include cutting-edge technological advancements and their advantages for enhancing biotech items. Government funding and technical assistance provided to biotech companies is pushing market growth even more.

Innovations and advent of novel technologies will accelerate the biotechnology market value:

By merging cutting-edge technology, expanding developments in the life sciences are providing significant advantages for healthcare interventions and productivity. Innovative technique development and company adoption have a beneficial impact on the biotech industry and are expected to drive significant market growth. Medicine is utilising cutting-edge technologies, such as 3D bio printing. Heart valves, cartilage, and skin are just a few of the bodily parts that may be developed using 3D bio printing and living cells. The development of medications, tissues, and organs like the liver and heart utilising patient body cells has a tremendous potential. The spectrum of uses for human cells and tissues in medical research will be further expanded because accurate models for research and analysis will be made available.

The market for fermentation in biotechnology is expected to reach USD 57 billion in 2020, driven by a variety of applications that combine higher results with low costs and environmental friendliness. Antibiotics, probiotics, intermediary molecules like citric acid, and other medical items have all been produced using fermentation technology to a large extent.

A CAGR of over 9.2% CAGR is predicted for the U.S. biotechnology market through 2027 due to the existence of significant market players, high healthcare spending, and considerable R&D activities. The OECD research estimates that in June 2018, the United States invested over 17.2% of its GDP in its healthcare systems. Thermo Fisher Scientific Inc. also contributed $475 million to the expansion of the pharmaceutical, biologics,, cell and gene therapy. Rising number of companies in the region receiving product approvals will enhance the industry value.

Recent industry developments:

Pharmaceutical Product Development (PPD), a clinical research business, will be purchased by Thermo Fischer Scientific for USD 17.4 billion in April 2021. By increasing its investment in drug development, this acquisition would help the company commercialise therapeutic discoveries and continue its growth in the clinical research market.

Amgen and Rodeo Therapeutics Corporation (Rodeo) came into an agreement in March 2021 for Amgen to purchase Rodeo. Rodeo is a biopharmaceutical business that develops small-molecule therapeutics for the regeneration and repair of specific tissues. Amgen will be able to offer cutting-edge biopharmaceutical products thanks to this acquisition, which will also help them regain market share.


Associations and Organizations

American Institute for Medical and Biological Engineering (AIMBE)

American Medical Informatics Association (AMIA)

Biomedical Engineering Society (BMES)

European Molecular Biology Organization (EMBO)

Genetics Society of America (GSA)

International Federation for Medical and Biological Engineering (IFMBE)


Past conference Report

Biotechnology 2022 Report

LexisConferences Conferences hosted the event “25th Global Congress on Biotechnology” at Paris, France during August 22-33, 2022. The conferences were organized with a focus on the themes “Biotechnology Research to meet the Emerging demands” was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering.

The event proceedings were carried out through several Scientific-sessions and plenary lectures, LexisConferences Conference would like to express a sincere thankfulness to all the Honourable guests and Keynote Speakers of 25th Global Congress on Biotechnology. We would like to convey a warm gratitude to all the Honourable guests and Keynote Speakers of Biotechnology 2022.

Biotechnology 2022 committee would like to convey a warm gratitude to all the Honourable guests and Keynote Speakers, G Saucedo from Aigües de Barcelona Spain; Abdelfateh Kerrouche from Edinburgh Napier University UK; Sophie Vazulka from University of Natural Resources and Life Sciences Austria, Austria; Selva M Athi Narayanan from Edinburgh Napier University UK; Alyssa L. Decker from Pennsylvania State University USA; Yuichiro Otsuka from Forestry and Forest Products Research Institute Japan have given a wonderful talk which makes allows the delegates and other attendees to gain the knowledge about main course of the event.

Biotechnology 2022 Organizing Committee would like to thank the Moderator of the conference, Dr Klaus Ammann from Emeritus Professor University of Bern, Switzerland, who contributed a lot for the smooth functioning of this event and for taking up the responsibility to coordinate during the sessions for smooth functioning of this event. We are indebted to your support.

LexisConferences conferences also took the privilege of felicitating Biotechnology 2022 Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs, Young Researchers and other attendees whose support made the conference a great success.

We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events. We would also like to thank Chairs and Co-chairs of the conference, Dr. Synan AbuQamar from Professor United Arab Emirates University UAE; cristina-crenguta-albu  from Associate Professor University of Medicine and Pharma, Romania for a being a great support for our event to be a grand success.

A series of lectures by distinguished professionals discussed the recent trends and issues in inter-disciplinary Rheumatology and its technical advancements.

Save your dates for the most awaited event of 2020

With a great response and feedback which we received from participants and supporters from Rheumatology 2019, we are proud to announce our upcoming conferences in the Series 26th Global Congress on Biotechnology on March 21-22, 2023 in Chicago, USA with the theme of Exploration of the latest applications in the field of Biotechnology

Some of our conference images are as follows:

The main aim of this conference is to solicit the gracious presence of our honourable, to the upcoming conference “26th Global Congress on Biotechnology” that is going to be held during March 21-22, 2023 in Chicago, USA, to share and exchange their knowledge.

It is an International platform for business delegates, B2B meetings, poster presentations, workshops, symposia, networking and more. It will offer a platform wherein you can ensure enormous exposure and networking by exhibiting products and services. Grab the opportunities, and share your innovative ideas, new technologies and recent researches.

Biotechnology 2023 witnesses an amalgamation of peerless speakers who enlightened the gathering with their contribution towards the prevention of Biotechnology related difficulties, its effects and treatment on Biotechnology.

For being a Experts in Biotechnology, we hope that this platform gives knowledge and new updates by undergoing with the several interactive sessions to encourage the exchange of innovative ideas in the field of Biotechnology and its advancements, in that all the session talks are consider to be a great talks which makes the delegates, exhibitor, collaborators and other speakers feels so much interesting.

Being a significant expert in this area we would like to Invite you as an International Organizing Committee Members, Speakers, Keynote speakers, Young Research forum, Sponsors and Exhibitor, etc. for Biotechnology 2023. Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Molecular, Cancer, and Plant Biotechnology and share the cross-cultural experiences of various principles and practices.

The centre of the activity of Biotechnology 2023 is to produce the clear visual definition by undergoing with Oral Presentation, Poster presentation, Workshop, Exhibition, networking and interacting session

With the feedback from your renowned Speakers, we have added some of the new Session tracks that needs to be focused such as such as Cell Molecular biotechnology, Cancer Biotechnology, Algal Biotechnology, Environmental Biotechnology, Biotechnology Engineering, Applied Immunology, Marine Biotechnology, Biotechnology Applications, Bio pharming etc.

With the great support we have successfully completed Biotechnology 2023 and we are expecting huge response and support from the Biotechnology Doctors, Biotechnology Professionals, Young researchers, Students, Delegates, Directors and other Biotechnology related companies to have your gracious presence at Biotechnology 2023 on March 21-22, 2023 in Chicago, USA to make this congress a great successful event of the year 2023

Join our team Biotechnology 2023 at this beautiful city of USA and let’s make this professional gathering a Great success

Contact us:

Freya Adam

Program Manager

Biotechnology 2023


Alejandro De La Parra Solomon
Chief Strategy Office Co-founder at Quantum Brain Research Institute
University of Washington


Alejandro De La Parra Solomon is an entrepreneur based in Tallinn, Estonia that is focused on the Information Technology, Education, Health, International Trade, and Real Estate industry sectors. He is creative, results-driven, and has 18+ years of Digital Strategy experience in IT architecture, marketing, and IT implementation.

Alejandro serves as CEO and Cofounding Partner at The Solomon Brokerage Firm / Solomon Real Estate, and functions as Chief Strategy Officer at Quantum Brain Research Institute in Estonia. He is also the Lead Digital Strategist of the VTBCommunity Foundation, a predictable finance-focused blockchain initiative in Gibraltar.

Within the academic and educational fields, Alejandro acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer, and is a Cofounding Partner at The Reprogramming Medicine Association. He is also a member of Singularity University and of OpenExo.

In relation to nonprofit organizations, he has served as a member of the Laurentia Project and of Cerebro Mexico. He currently serves as an Advisory Board member of the Lifeboat Foundation and as an Advisory Board member of the Future Worlds Center – Cyprus Neuroscience & Technology Institute (Senior TV Program). He is a voting citizen and is running for Mayor and as future Parliamentary Candidate at Asgardia. He also served as the founder and former Board of Directors of Astrum Fundacion, and was the Digital Strategy Advisor for POKI Ciudad Organica. He is also a part of the General Member Board at the National Autism Association, the National Fibromyalgia Association, the International Literacy Association, and the United Spinal Association.

In the logistics and international trade sector, he is the former President & Co-founder of PetroM Renewable, and served as Vice President of Operations & Strategy at PetroM Corp across all of its divisions, including PetroM Logistics.

In the Biotech sphere, he served as COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. He is the former CEO & Founder of Astrum Salud Movil and its Telemedicine service Astrum Movil, former Digital Strategy Director & Co-founder of Dr. Jois, BiorganicAging, and What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marketing Officer at ReAnima Advanced Biosciences, a project launched by Bioquark, Inc., where he was also serving as Digital Media Director. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense.

In the editorial and publishing sector, he is former CITO & Senior Partner of Cerezo Editores, an epistemology publishing company in Mexico.

Alejandro is also a member of several associations pertaining Information Technology advocacy and development including the World Blockchain Association, the Computing Technology Industry Association, the Internet Marketing Association, the Application Developers Alliance, and the Association of Strategic Marketing.

Alejandro’s activities in arts & culture involve his membership in Sociedad de Autores y Compositores de Mexico (SACM). He also served as Digital Strategy Advisor at Xicome Festival. He is a multimedia professional featured in IMDB, SoundCloud, and ReverbNation and has had activities in the entertainment industry as a music producer, composer & arranger for Televisa with broadcast television, film, radio, and web, receiving international awards and aired content on more than 185 countries.

In the energy sector, he worked as the Vice President of Strategy & Operations of PetroM Energy, and is a member of the National Introducing Brokers Association, and a part of the National Biodiesel Board (Alliance Program).

Researches :

  • Neuroscience & Blockchain
Dr Thakur Bahadur Singh Rajput
Adjunct Professor
Indian Agricultural Research Institute IARI, New Delhi


Dr. T B S Rajput is an Adjunct Professor at Indian Agricultural Research Institute (IARI), New Delhi and Professor Jai Shankar Telangana State Agricultural University, Hyderabad, India and a Visiting Professor at Asian Institute of Technology, Bangkok, Thailand. He has over forty years of experience of research and post graduate teaching in the field of Soil and Water Conservation Engineering. He is a former Project Director of Water Technology Centre at IARI and a scientist of national repute in agricultural Water management and hi-tech horticulture. He has published ten books and more than 200 research articles. He has developed seven computer softwares on different aspects of agricultural water management. Besides research, he has supervised more than twenty post graduate researches. He was adjudged as the Best teacher by Indian Agricultural Research Institute and was awarded the best teacher by Indian Council of Agricultral Research. He has received many honours and awards for research including the prestigious Rafi Ahmed Kidwai Award, the highest award an Agricultural Scientist can get in India. He is widely travelled and is a Fellow of National Academy of Agricultural Sciences and six other National Scientific Societies in India.

Researches :

  • He is a former Project Director of Water Technology Centre at IARI and a scientist of national repute in agricultural Water management and hi-tech horticulture. Areas of interest: Agriculture production system and hi-tech horticulture
Chua Lee Suan
Associate professor
Universiti Teknologi Malaysia


Chua Lee Suan is an associate professor of the Department of Bioprocess and Polymer Engineering, School of Chemical and Energy Engineering, Faculty of Engineering, Universiti Teknologi Malaysia. She is also a research fellow in the Institute of Bioproduct Development.

Researches :

  • Her research scopes are mainly focused on LC-MS/MS based metabolomics, phytochemical profiling, herbal extraction & standardization, and honey & honey bees related product development. She has many research contracts with private companies, and providing consultancy for herbal quality and product development. Her active involvement in research activities can also be seen from her published articles, and the commitment as journal reviewer and editor for many well-known international journals. She is also a registered chemist from the Malaysian Institute of Chemistry, and an assessor of Standards Malaysia for SAMM ISO/IEC 17025 accreditation in testing laboratories.
Abdullah Iqbal
Bangladesh Agricultural University BAU, Mymensingh


Abdullah Iqbal is a Professor in the Department of Food Technology & Rural Industries, Bangladesh Agricultural University (BAU), Mymensingh, Bangladesh. He received his PhD in the field of "Computer Vision and Hyperspectral Imaging" from School of Biosystems Engineering, University College Dublin (UCD), Ireland. He also worked as Research fellow in the National Agriculture and Food Research Organization (NARO), Tsukuba, Japan. He has completed several National and International funded research projects and supervised more than 50 MS (Master of Science in Food Engineering) student’s research projects.

Researches :

  • His research interest includes Food dehydration and fermentation, quality evaluation and/or authentication of different food products using computer vision and Spectroscopy (i.e., Fluorescence, Raman and NIR spectroscopy).
Narges Shahgholian
Assistant Professor
Shahid Chamran University SCU,Ahvaz,Iran


Narges Shahgholian is an Assistant Professor of Food Science and Engineering at Shahid Chamran University (SCU) of Ahvaz. She received her PhD in Food Engineering in the field of "Food Chemistry & Nanotechnology", Mashhad, RIFST in 2016. Experiences & Executive Records: 5+ years of experience in Food Industries Sector. Specially "Dairy and Supplement Industry/Technology of infant formula" and Edible Oil Technology". She has 14+ certificate of skills training (ex, Infant formula plant commissioning, Advance in Protein & Carbohydrate Chemistry, Analytical Chemistry, Instrumental Rheology, Modern Food Technology, Statistics in Process optimization, TQM). She has been 35+ food factory visiting and internship in Iran and Germany. TEACHING AND TRAINING EXPERIENCE: • Food Chemistry & Analytical Chemistry, Azad University, B.S level, 2010. • Food Quality Control, (Theory & Practical), Azad University, B.S level, 2009-2010. • Edible oils technology, University of Applied Sciences, M.Sc. level, 2016. • Evaluation of solid and liquid tissues in food industry, Azad University, Ph.D level, 2017. • Effect of process on food quality / new processes, Azad University, Ph.D. level, 2016-2017. • Research Methods, SCU, M.Sc. level, 2019-2021. • Food Microbiology, (Theory & Practical), SCU, B.S level, 2019-2021. • Food Biochemistry, SCU, B.S level, 2019-2021. • Food industries (1, 2, 3), SCU, B.S level, 2019-2021. • Basics of plant products processing, (Theory & Practical), SCU, B.S level, 2021. • Unit Operation (3), SCU, B.S level, 2021. • Project (1,2,3) (for food machines students), SCU, B.S level, 2020-2021.

Researches :

  • Interests and Research Fields: Motivation to work as part of a team in an interdisciplinary environment; Nutraceutical & bioactive delivery/ Supplement Industry/ Food process engineering: "Advanced Methods in Encapsulation rely on biopolymers & Nanotech" Application of HPUS in food industry. Scale-up of value added products of agricultural wastes;
Dr Shahrul Razid Sarbini
Associate professor
Universiti Putra Malaysia Kampus Bintulu Sarawak


Shahrul Razid Sarbini is an Associate Professor at the Faculty of Agricultural Science and Forestry, Universiti Putra Malaysia. He graduated from Universiti Malaysia Sarawak (UNIMAS) in 2003 in Resource Biotechnology, followed by a M.Sc. in Food Biotechnology from UNIMAS as well, in 2007. He then obtained a Ph.D. in Food and Nutritional Sciences from the University of Reading, UK in 2011.

Researches :

  • His expertise is in the field of Functional Food. His major interests are in the field of prebiotic, probiotic and gut microbiota. He has published numerous papers associated with the prebiotic evaluation of local food, gut microbiota assessment, starch modification, together with functional food enhancement. He has also spoken in various conferences and seminars related to his expertise. He is currently the Director of Campus, Universiti Putra Malaysia Bintulu Sarawak Campus.
Emmanuel Mic Drakakis
Imperial College London

Patricia E Berg
George Washington University Medical Center

Maria-Joo R P Queiroz
University of Minho Portugal

Mark Bronstrup
Helmholtz Centre for Infection Research

Helena Barreto Henriksson
Sahlgrenska University Hospital

Bernard Faye
FAO Consultant France

Our Collaborations, Sponsors, Media Partners